AU Patent

AU2014268477A1 — Compounds for treatment of drug resistant and persistent tuberculosis

Assigned to Scripps Research Institute · Expires 2015-11-12 · 11y expired

What this patent protects

Described herein are compounds and compositions for treating drug resistant and persistent tuberculosis. Also described herein is a method of screening for identifiying biofilm formation inhibitors.

USPTO Abstract

Described herein are compounds and compositions for treating drug resistant and persistent tuberculosis. Also described herein is a method of screening for identifiying biofilm formation inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number: AU2014268477A1
Jurisdiction: AU
Classification: —
Expires: 2015-11-12
Drug substance claim: No
Drug product claim: No
Assignee: Scripps Research Institute
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.